Disease management programs (DMPs) are defined as “structured treatment plans that aim to help people manage their chronic disease in a better way and to maintain as well as improve quality of life”. The main components of disease management programs are mentioned in Figure 1. Figure 1: Components of Disease Management Software By application, the…
Breast cancer is a growing concern as it is reported to be the most common cancer in women worldwide. About 1.7 million new cases and 5,22,000 deaths from breast cancer occur every year. The number of deaths due to breast cancer (3,24,000) are high, in low and middle-income countries. Risk Factors of Breast Cancer Risk factors…
Introduction A biosimilar product, as defined by USFDA, is “a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product.” By 2020, the biosimilar market is expected to reach $15 billion booming market, which is thrice the presentmarket(Ragunadhan 2018).Latest additions to this category of drugs are…
In the clinical trials industry, 80% of trials do not meet enrolment timelines, leading to a loss of $8 million per day. Delayed enrolment not only impacts trial timelines, but more trials are being cancelled because of it, preventing investigators from determining the safety and efficacy of what could be promising new therapies for patients…
It is estimated that nearly 44 million people worldwide have Alzheimer’s or related dementia. The total number of people with Alzheimer’s is projected to almost double every 20 years. What really scares me is Alzheimer’s or premature senility, losing that ability to read and enjoy and to write. And you do it, and some days…
